@article{08c6608b23694a59a3dabfcf0a0df914,
title = "Intranasal butorphanol rescue therapy for the treatment of intractable pruritus: A case series from the Johns Hopkins Itch Clinic",
author = "Raveena Khanna and Kwon, {Christina D.} and Patel, {Sagar P.} and Micah Belzberg and Williams, {Kyle A.} and Ramona Khanna and Emily Boozalis and Kwatra, {Shawn G.}",
note = "Funding Information: Funding sources: Dr Kwatra has received the Dermatology Foundation Medical Dermatology Career Development Award.Conflicts of interest: Dr Kwatra is on the scientific advisory board for Incyte Corporation, Pfizer Inc, Regeneron Pharmaceuticals, and Menlo Therapeutics and has received grant funding from Galderma SA, Kiniksa Pharmaceuticals, and Pfizer Inc. Authors Khanna, Khanna, and Williams and Drs Kwon, Patel, Belzberg and Boozalis have no conflicts of interest to declare.IRB approval status: Approval was granted by the Johns Hopkins Medicine Institutional Review Board. Patient consent was not required.",
year = "2020",
month = nov,
doi = "10.1016/j.jaad.2020.07.017",
language = "English (US)",
volume = "83",
pages = "1529--1533",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "5",
}